Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Emilie Hutt"'
Autor:
Antoine Adenis, Stéphanie Delaine-Clisant, Emilie Hutt, Diane Pannier, Marie-Cécile Le Deley, Arlette Da Silva, Emilie Bogart, Sara Le Lay-Diomande
Publikováno v:
BMJ Open
BMJ Open, BMJ Publishing Group, 2018, 8 (1), pp.e015904. ⟨10.1136/bmjopen-2017-015904⟩
BMJ Open, 2018, 8 (1), pp.e015904. ⟨10.1136/bmjopen-2017-015904⟩
BMJ Open, BMJ Publishing Group, 2018, 8 (1), pp.e015904. ⟨10.1136/bmjopen-2017-015904⟩
BMJ Open, 2018, 8 (1), pp.e015904. ⟨10.1136/bmjopen-2017-015904⟩
International audience; INTRODUCTION : Palliative care (PC) has usually been offered at the end-of-life stage, although the WHO recommends providing PC as early as possible in the course of the disease. A recent study has shown that early PC (EPC) pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6b76dcbf2bbd53a84f51f2103898980
https://hal.umontpellier.fr/hal-02282769/file/e015904.full.pdf
https://hal.umontpellier.fr/hal-02282769/file/e015904.full.pdf
Autor:
Robert L. Coleman, Christine L. Clarke, Keiichi Fujiwara, Erard M. Gilles, Jacques Bonneterre, Jacques Bosq, Matthew A. Powell, Bradley J. Monk, Alexander Zukiwski, J. Dinny Graham, Emilie Hutt, Thomas J. Herzog, Eric Leblanc
Publikováno v:
Gynecologic oncology. 138(3)
Objective Hormonal therapy is generally reserved for patients with endometrial cancers that fail cytotoxic chemotherapy, but there is a lack of sufficiently sensitive diagnostics to identify potential responders. We sought to develop a diagnostic tec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96c15b4f8da8a81baa2ffe3406b0bbcd
https://pubmed.ncbi.nlm.nih.gov/26142884
https://pubmed.ncbi.nlm.nih.gov/26142884
Autor:
Emilie Hutt, Jacques Bosq, Erard M. Gilles, Alexander Zukiwski, Charline Alleaume, Barthelemy Octavius Gilles, Jacques Bonneterre
Publikováno v:
Journal of Clinical Oncology. 32:3046-3046
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9df7833638d514a4fb2ec84720059564
https://doi.org/10.1200/jco.2014.32.15_suppl.3046
https://doi.org/10.1200/jco.2014.32.15_suppl.3046
Autor:
Erard M. Gilles, Jacques Bonneterre, Jacques Bosq, Alexander Zukiwski, Alexander Valent, Emilie Hutt, Suzanne A. W. Fuqua
Publikováno v:
Journal of Clinical Oncology. 31:592-592
592 Background: About 50% of ER positive (ERpos) BC are resistant to hormone treatment. In absence of ligand, ERs are evenly distributed in nuclei in normal tissue. Upon ligand binding, ERs dimerizes and form a discrete focal subnuclear distribution
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af831fb57b811e71e2cd9b33f1ae8ff2
https://doi.org/10.1200/jco.2013.31.15_suppl.592
https://doi.org/10.1200/jco.2013.31.15_suppl.592